{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:24:18Z","timestamp":1764937458571,"version":"3.41.2"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["401851\/2015-0"],"award-info":[{"award-number":["401851\/2015-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006506","name":"Minist\u00e9rio da Sa\u00fade","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006506","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>The influenza A virus (IAV) is of a major public health concern as it causes annual epidemics and has the potential to cause pandemics. At present, the neuraminidase inhibitors (NAIs) are the most widely used anti-influenza drugs, but, more recently, the drug baloxavir marboxil (BXM), a polymerase inhibitor, has also been licensed in some countries. Mutations in the viral genes that encode the antiviral targets can lead to treatment resistance. Worldwide, a low prevalence of antiviral resistant strains has been reported. Despite that, this situation can change rapidly, and resistant strain surveillance is a priority. Thus, the aim of this was to evaluate Brazilian IAVs antiviral resistance from 2017 to 2019 through the identification of viral mutations associated with reduced inhibition of the drugs and by testing the susceptibility of IAV isolates to oseltamivir (OST), the most widely used NAI drug in the country. Initially, we analyzed 282 influenza A(H1N1)pdm09 and 455 A(H3N2) genetic sequences available on GISAID. The amino acid substitution (AAS) NA:S247N was detected in one A(H1N1)pdm09 strain. We also identified NA:I222V (<jats:italic>n<\/jats:italic> = 6) and NA:N329K (<jats:italic>n<\/jats:italic> = 1) in A(H3N2) strains. In addition, we performed a molecular screening for NA:H275Y in 437 A(H1N1)pdm09 samples, by pyrosequencing, which revealed a single virus harboring this mutation. Furthermore, the determination of OST IC<jats:sub>50<\/jats:sub> values for 222 A(H1N1)pdm09 and 83 A(H3N2) isolates revealed that all isolates presented a normal susceptibility profile to the drug. Interestingly, we detected one A(H3N2) virus presenting with PA:E119D AAS. Moreover, the majority of the IAV sequences had the M2:S31N adamantanes resistant marker. In conclusion, we show a low prevalence of Brazilian IAV strains with NAI resistance markers, in accordance with what is reported worldwide, indicating that NAIs still remain an option for the treatment of influenza infections in Brazil. However, surveillance of influenza resistance should be strengthened in the country for improving the representativeness of investigated viruses and the robustness of the analysis.<\/jats:p>","DOI":"10.3389\/fpubh.2022.944277","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T09:50:21Z","timestamp":1663149021000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Low prevalence of influenza A strains with resistance markers in Brazil during 2017\u20132019 seasons"],"prefix":"10.3389","volume":"10","author":[{"given":"Thiago das Chagas","family":"Sousa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Santa Cruz Carvalho","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milene Dias","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana Couto","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola Cristina","family":"Resende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cliomar A.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria do Carmo","family":"Debur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Ribeiro","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea Cony","family":"Cavalcanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana Sch\u00e4ffer","family":"Gregianini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe Campos de Melo","family":"Iani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicidade Mota","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra Bianchini","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessylene de Almeida","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia Correa de Oliveira","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Motta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walquiria Aparecida Ferreira de","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilda Mendon\u00e7a","family":"Siqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline da Rocha","family":"Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(17)33293-2","article-title":"Estimates of global seasonal influenza-associated respiratorymortality: amodelling study","volume":"391","author":"Iuliano","year":"2018","journal-title":"Lance"},{"key":"B2","first-page":"1151","volume-title":"Fields Virology","author":"Shaw","year":"2013"},{"key":"B3","first-page":"1855","article-title":"Influenza. In: Coura JR, editor","volume-title":"Din\u00e2mica das doen\u00e7as infecciosas e parasit\u00e1rias","author":"Siqueira","year":"2015"},{"key":"B4","first-page":"1","article-title":"Influenza: Monitoramento at\u00e9 a Semana Epidemiol\u00f3gica 52 de 2015","volume":"47","author":"Secretaria","year":"2019","journal-title":"Bol Epidemiol\u00f3gico"},{"key":"B5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/vim.2017.0141","article-title":"Influenza virus: dealing with a drifting and shifting pathogen","volume":"31","author":"Kim","year":"2018","journal-title":"Viral Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"SD008965","DOI":"10.1002\/14651858.CD008965.pub4","article-title":"Neuraminidase inhibitors for preventing and treating influenza in adults and children","volume":"2014","author":"Jefferson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/QCO.0000000000000113","article-title":"Developments in the treatment of severe influenza: lessons from the pandemic of 2009 and new prospects for therapy","volume":"27","author":"Zambon","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1002\/j.1460-2075.1985.tb04038.x","article-title":"The molecular basis of the specific anti-influenza action of amantadine","volume":"4","author":"Hay","year":"1985","journal-title":"EMBO J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s40265-018-0899-1","article-title":"Baloxavir: first global approval","volume":"78","author":"Heo","year":"2018","journal-title":"Drugs."},{"key":"B11","unstructured":""},{"key":"B12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1001\/jama.295.8.joc60020","article-title":"Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States","volume":"295","author":"Bright","year":"2006","journal-title":"J Am Med Assoc."},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.47.17-00731","article-title":"Detection of adamantane-sensitive influenza A(H3N2) viruses in Australia, 2017: a cause for hope?","volume-title":"Eurosurveillance.","author":"Hurt","year":"2017"},{"key":"B14","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.antiviral.2009.03.003","article-title":"Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa","volume":"83","author":"Hurt","year":"2009","journal-title":"Antiviral Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.antiviral.2015.02.003","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014","volume":"117","author":"Takashita","year":"2015","journal-title":"Antiviral Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"104718","DOI":"10.1016\/j.antiviral.2020.104718","article-title":"Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018","volume":"175","author":"Takashita","year":"2020","journal-title":"Antiviral Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.antiviral.2016.06.001","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015","volume":"132","author":"Hurt","year":"2016","journal-title":"Antiviral Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"105281","DOI":"10.1016\/j.antiviral.2022.105281","article-title":"Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020","volume":"200","author":"Govorkova","year":"2022","journal-title":"Antiviral Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.antiviral.2017.08.004","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016","volume":"146","author":"Gubareva","year":"2017","journal-title":"Antiviral Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.antiviral.2018.07.001","article-title":"Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017","volume":"157","author":"Lackenby","year":"2018","journal-title":"Antiviral Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-27890-4","article-title":"Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil","volume":"8","author":"Omoto","year":"2018","journal-title":"Sci Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2807\/1560-7917.ES.2019.24.3.1800666","article-title":"Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016\/17 and 2017\/18 seasons","volume":"24","author":"Gubareva","year":"2019","journal-title":"Eurosurveillance."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2807\/1560-7917.ES.2019.24.12.1900170","article-title":"Influenza a(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019","volume":"24","author":"Takashita","year":"2019","journal-title":"Eurosurveillance."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.02718-20","article-title":"Whole-genome analysis surveillance of influenza a virus resistance to polymerase complex inhibitors in Eastern Spain from 2016 to 2019","volume":"65","author":"Mengual-Chuli\u00e1","year":"2021","journal-title":"Antimicrob Agents Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1590\/0074-02760140330","article-title":"Oseltamivir-resistant influenza A(H1N1)pdm2009 strains found in Brazil are endowed with permissive mutations, which compensate the loss of fitness imposed by antiviral resistance","volume":"110","author":"Lopes E Souza","year":"2015","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e80081","DOI":"10.1371\/journal.pone.0080081","article-title":"Detection of oseltamivir-resistant pandemic influenza A(H1N1)pdm2009 in Brazil: can community transmission be ruled out?","volume":"8","author":"Souza","year":"2013","journal-title":"PLoS ONE."},{"key":"B27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.antiviral.2018.03.010","article-title":"Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014-2016 seasons: identification of strains bearing mutations associated with reduced inhibition profile","volume":"154","author":"Matos","year":"2018","journal-title":"Antiviral Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3855\/jidc.7135","article-title":"Influenza in Brazil: surveillance pathways","volume":"10","author":"Cantarino","year":"2016","journal-title":"J Infect Dev Ctries."},{"volume-title":"Pyrosequencing Analysis Protocol for the Detection of the Substitution at Residue 275 in the Neuraminidase of 2009 Pandemic H1N1 Viruses Using the PyroMark TM Q24 Platform November 2012 Pyrosequencing Analysis Protocol for the Detection of the Substitution","year":"2012","key":"B29"},{"key":"B30","first-page":"369","volume":"87","year":"2012","journal-title":"Relev Epidemiol Hebd"},{"key":"B31","unstructured":"BrasilM da sa\u00fade,. Guia de vigil\u00e2ncia em sa\u00fade 3a edi\u00e7\u00e3o. BRASIL, Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Coordena\u00e7\u00e3o-Geral de Desenvolvimento da Epidemiologia em Servi\u00e7os.\n          p. 7412019"},{"key":"B32","unstructured":""},{"key":"B33","doi-asserted-by":"publisher","first-page":"6317","DOI":"10.1016\/j.vaccine.2009.07.017","article-title":"Structural basis for oseltamivir resistance of influenza viruses","volume":"27","author":"Collins","year":"2009","journal-title":"Vaccine."},{"key":"B34","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1177\/135965350400900404","article-title":"A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A\/H1N1 virus","volume":"9","author":"Abed","year":"2004","journal-title":"Antivir Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"9427","DOI":"10.1128\/JVI.00373-10","article-title":"Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model","volume":"84","author":"Hurt","year":"2010","journal-title":"J Virol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"19884","DOI":"10.2807\/ese.16.23.19884-en","article-title":"Increased detection in Australia and Singapore of a novel influenza a(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation","volume":"16","author":"Hurt","year":"2011","journal-title":"Eurosurveillance."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1128\/AAC.05994-11","article-title":"Impact of mutations at residue I223 of the neuraminidase protein on the resistance profile, replication level, and virulence of the 2009 pandemic influenza virus","volume":"56","author":"Pizzorno","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1086\/508777","article-title":"Characterization of multidrug-resistant influenza A\/H3N2 viruses shed during 1 year by an immunocompromised child","volume":"43","author":"Baz","year":"2006","journal-title":"Clin Infect Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1086\/518936","article-title":"Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide","volume":"196","author":"Deyde","year":"2007","journal-title":"J Infect Dis."},{"key":"B40","unstructured":"2019"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/molbev\/msm103","article-title":"The genesis and spread of reassortment human influenza A\/H3N2 viruses conferring adamantane resistance","volume":"24","author":"Simonsen","year":"2007","journal-title":"Mol Biol Evol."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.944277\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T09:50:38Z","timestamp":1663149038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.944277\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":41,"alternative-id":["10.3389\/fpubh.2022.944277"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.944277","relation":{},"ISSN":["2296-2565"],"issn-type":[{"type":"electronic","value":"2296-2565"}],"subject":[],"published":{"date-parts":[[2022,9,14]]},"article-number":"944277"}}